Dose related effects of the kappa agonist U-50, 488H on behaviour, nociception and autonomic response in the horse.

The research article investigates the effects of the kappa agonist U-50, 488H on behaviour, nociception, and autonomic response in horses, suggesting it as a prospective analgesic for equine medicine due to its fewer stimulatory actions.

About kappa agonist U-50,488H

• U-50,488H is an experimental narcotic analgesic that works as a selective kappa agonist. Kappa agonists are considered to provide effective pain relief without causing substantial central nervous system stimulation.
• This research explored the effects of U-50,488H on horses and found it to provide good and long-lasting analgesia for at least 120 minutes, surpassing the effectiveness of other mu-agonists that were tested on horses.

Effect on locomotor response

• The researchers assessed the locomotor response of the horses to U-50,488H. The response was notably lower than that observed with other narcotic analgesics, like ethylketazocine and butorphanol.
• U-50,488H resulted in the least locomotor response among all the narcotic analgesics that were tested, suggesting fewer stimulatory side effects.

Autonomic responses and naloxone

• The study also indicated that the autonomic responses to U-50,488H were less extreme than those to other narcotic analgesics. Autonomic responses relate to the involuntary functions of the body, such as heart rate or pupil dilation.
• Furthermore, it was discovered that the analgesic response induced by U-50,488H could be blocked by naloxone, a medication used to reverse the effects of opioids.

Prompting Future Applications

• Given the analgesic abilities of U-50,488H with fewer stimulatory actions, the researchers proposed that U-50,488H could potentially serve as a useful narcotic analgesic in equine medicine.
• The findings underscore the need for further exploration and evaluation of U-50,488H for its therapeutic potential in treating pain in horses.